Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport

Affiliations

¹ Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
² Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Published Erratum

Tim Quach et al. Front Pharmacol. 2022.

. 2022 Sep 5:13:1014363.

doi: 10.3389/fphar.2022.1014363. eCollection 2022.

¹ Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
² Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.879660.].

Keywords: buprenorphine; first-pass metabolism; lymphatic transport; opioid analgesics; oral bioavailability; prodrug; triglyceride mimetic.

Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport.
Quach T, Hu L, Han S, Lim SF, Senyschyn D, Yadav P, Trevaksis NL, Simpson JS, Porter CJH. Quach T, et al. Front Pharmacol. 2022 Apr 12;13:879660. doi: 10.3389/fphar.2022.879660. eCollection 2022. Front Pharmacol. 2022. PMID: 35496278 Free PMC article.